189 related articles for article (PubMed ID: 18829550)
21. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway.
Wang Z; Jia G; Li Y; Liu J; Luo J; Zhang J; Xu G; Chen G
Oncotarget; 2017 Apr; 8(14):22563-22580. PubMed ID: 28186966
[TBL] [Abstract][Full Text] [Related]
22. p21-activated kinase 1: PAK'ed with potential.
Ong CC; Jubb AM; Zhou W; Haverty PM; Harris AL; Belvin M; Friedman LS; Koeppen H; Hoeflich KP
Oncotarget; 2011 Jun; 2(6):491-6. PubMed ID: 21653999
[TBL] [Abstract][Full Text] [Related]
23. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.
Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin HM; Fernandez-Valle C
Oncogene; 2024 Mar; 43(13):921-930. PubMed ID: 38336988
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
26. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
[TBL] [Abstract][Full Text] [Related]
27. Reduced RAC1 activity inhibits cell proliferation and induces apoptosis in neurofibromatosis type 2(NF2)-associated schwannoma.
Wang Y; Wang B; Li P; Zhang Q; Liu P
Neurol Res; 2017 Dec; 39(12):1086-1093. PubMed ID: 28934903
[TBL] [Abstract][Full Text] [Related]
28. Neuronal filopodium formation induced by the membrane glycoprotein M6a (Gpm6a) is facilitated by coronin-1a, Rac1, and p21-activated kinase 1 (Pak1).
Alvarez Juliá A; Frasch AC; Fuchsova B
J Neurochem; 2016 Apr; 137(1):46-61. PubMed ID: 26809475
[TBL] [Abstract][Full Text] [Related]
29. Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors.
Manchanda PK; Jones GN; Lee AA; Pringle DR; Zhang M; Yu L; La Perle KM; Kirschner LS
Oncogene; 2013 Jul; 32(30):3491-9. PubMed ID: 23045281
[TBL] [Abstract][Full Text] [Related]
30. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.
Mercado-Pimentel ME; Miller C; Rolph DN; Villalobos EF; Dunn AM; Mohan PM; Igarashi S; Liu X; Yrun-Duffy M; Patel NK; Read CM; Francis RH; Lane AI; Murugesh S; Jacob A
Otol Neurotol; 2017 Jan; 38(1):139-146. PubMed ID: 27755359
[TBL] [Abstract][Full Text] [Related]
33. Differential gene expression between human schwannoma and control Schwann cells.
Hanemann CO; Bartelt-Kirbach B; Diebold R; Kämpchen K; Langmesser S; Utermark T
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):605-14. PubMed ID: 17083475
[TBL] [Abstract][Full Text] [Related]
34. PAK1 as a therapeutic target.
Kichina JV; Goc A; Al-Husein B; Somanath PR; Kandel ES
Expert Opin Ther Targets; 2010 Jul; 14(7):703-25. PubMed ID: 20507214
[TBL] [Abstract][Full Text] [Related]
35. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression.
Cooper J; Li W; You L; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
Sci Signal; 2011 Aug; 4(188):pt6. PubMed ID: 21878678
[TBL] [Abstract][Full Text] [Related]
36. P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α.
Liu KH; Huynh N; Patel O; Shulkes A; Baldwin G; He H
Cancer Lett; 2013 Oct; 340(1):22-9. PubMed ID: 23811286
[TBL] [Abstract][Full Text] [Related]
37. The role of insulin-like growth factors signaling in merlin-deficient human schwannomas.
Ammoun S; Schmid MC; Ristic N; Zhou L; Hilton D; Ercolano E; Carroll C; Hanemann CO
Glia; 2012 Nov; 60(11):1721-33. PubMed ID: 22821509
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells.
Kaempchen K; Mielke K; Utermark T; Langmesser S; Hanemann CO
Hum Mol Genet; 2003 Jun; 12(11):1211-21. PubMed ID: 12761036
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of p21 activated kinase (PAK) reduces airway responsiveness in vivo and in vitro in murine and human airways.
Hoover WC; Zhang W; Xue Z; Gao H; Chernoff J; Clapp DW; Gunst SJ; Tepper RS
PLoS One; 2012; 7(8):e42601. PubMed ID: 22900031
[TBL] [Abstract][Full Text] [Related]
40. Schwannomas and their pathogenesis.
Hilton DA; Hanemann CO
Brain Pathol; 2014 Apr; 24(3):205-20. PubMed ID: 24450866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
